Health-Promoting Properties of Lactobacillus helveticus
- 2012
- Frontiers in Microbiology 3
- Valentina Taverniti
- S. Guglielmetti
- PubMed: 23181058
- DOI: 10.3389/fmicb.2012.00392
Abstract
Lactobacillus helveticus is an important industrial thermophilic starter that is predominantly employed in the fermentation of milk for the manufacture of several cheeses. In addition to its technological importance, a growing body of scientific evidence shows that strains belonging to the L. helveticus species have health-promoting properties. In this review, we synthesize the results of numerous primary literature papers concerning the ability of L. helveticus strains to positively influence human health. Several in vitro studies showed that L. helveticus possesses many common probiotic properties, such as the ability to survive gastrointestinal transit, adhere to epithelial cells, and antagonize pathogens. In vivo studies in murine models showed that L. helveticus could prevent gastrointestinal infections, enhance protection against pathogens, modulate host immune responses, and affect the composition of the intestinal microbiota. Interventional studies and clinical trials have also demonstrated a number of health-promoting properties of L. helveticus. Finally, several studies suggested that specific enzymatic activities of L. helveticus could indirectly benefit the human host by enhancing the bioavailability of nutrients, removing allergens and other undesired molecules from food, and producing bioactive peptides through the digestion of food proteins. In conclusion, this review demonstrates that in light of the scientific literature presented, L. helveticus can be included among the bacterial species that are generally considered to be probiotic.
Keywords: ACE inhibitory activity; Lactobacillus helveticus; Probiotic; host-bacteria cross-talk; immunomodulation.
Research Insights
Supplement | Health Outcome | Effect Type | Effect Size |
---|---|---|---|
Lactobacillus helveticus | Altered Intestinal Microbiota Composition | Beneficial | Moderate |
Lactobacillus helveticus | Enhanced Pathogen Protection | Beneficial | Moderate |
Lactobacillus helveticus | Improved Bioavailability | Beneficial | Moderate |
Lactobacillus helveticus | Increased Production of Bioactive Peptides | Beneficial | Moderate |
Lactobacillus helveticus | Modulated Host Immune Response | Beneficial | Moderate |
Lactobacillus helveticus | Reduced Gastrointestinal Infections | Beneficial | Moderate |
Lactobacillus helveticus L10 | Altered Intestinal Microbiota Composition | Beneficial | Moderate |
Lactobacillus helveticus L10 | Enhanced Gastrointestinal Survival | Beneficial | Moderate |
Lactobacillus helveticus L10 | Enhanced Pathogen Protection | Beneficial | Moderate |
Lactobacillus helveticus L10 | Improved Immunomodulation | Beneficial | Moderate |
Lactobacillus helveticus L10 | Improved Iron Absorption | Beneficial | Moderate |
Lactobacillus helveticus L10 | Increased Adhesion to Epithelial Cells | Beneficial | Moderate |
Lactobacillus helveticus L10 | Increased Production of Bioactive Peptides | Beneficial | Moderate |
Lactobacillus helveticus L10 | Reduced Gastrointestinal Infections | Beneficial | Moderate |
Lactobacillus helveticus LH76 | Enhanced Pathogen Protection | Beneficial | Moderate |
Lactobacillus helveticus LH76 | Improved Bioavailability | Beneficial | Moderate |
Lactobacillus helveticus LH76 | Increased Production of Bioactive Peptides | Beneficial | Moderate |
Lactobacillus helveticus LH76 | Modulated Microbiota Composition | Beneficial | Moderate |
Lactobacillus helveticus LH76 | Reduced Gastrointestinal Infections | Beneficial | Moderate |
Lactobacillus helveticus R0052 | Altered Intestinal Microbiota Composition | Beneficial | Moderate |
Lactobacillus helveticus R0052 | Enhanced Pathogen Protection | Beneficial | Moderate |
Lactobacillus helveticus R0052 | Improved Bioavailability | Beneficial | Moderate |
Lactobacillus helveticus R0052 | Improved Gastrointestinal Transit Survival | Beneficial | Moderate |
Lactobacillus helveticus R0052 | Improved Vaginal Epithelial Cell Adherence | Beneficial | Moderate |
Lactobacillus helveticus R0052 | Increased Production of Bioactive Peptides | Beneficial | Moderate |
Lactobacillus helveticus R0052 | Modulated Host Immune Response | Beneficial | Moderate |
Lactobacillus helveticus R0052 | Reduced Gastrointestinal Infections | Beneficial | Moderate |
Lactobacillus helveticus R0052 | Reduced Pathogenic Load | Beneficial | Moderate |
Lactobacillus helveticus Rosell-52 | Enhanced Pathogen Protection | Beneficial | Moderate |
Lactobacillus helveticus Rosell-52 | Improved Bioavailability | Beneficial | Moderate |
Lactobacillus helveticus Rosell-52 | Improved Gastrointestinal Health | Beneficial | Moderate |
Lactobacillus helveticus Rosell-52 | Modulated Host Immune Response | Beneficial | Moderate |
Lactobacillus helveticus Rosell-52ND | Altered Intestinal Microbiota Composition | Beneficial | Moderate |
Lactobacillus helveticus Rosell-52ND | Enhanced Gastrointestinal Survival | Beneficial | Moderate |
Lactobacillus helveticus Rosell-52ND | Enhanced Nutrient Bioavailability | Beneficial | Moderate |
Lactobacillus helveticus Rosell-52ND | Enhanced Pathogen Protection | Beneficial | Moderate |
Lactobacillus helveticus Rosell-52ND | Increased Adhesion to Epithelial Cells | Beneficial | Moderate |
Lactobacillus helveticus Rosell-52ND | Increased Production of Bioactive Peptides | Beneficial | Moderate |
Lactobacillus helveticus Rosell-52ND | Reduced Intestinal Infections | Beneficial | Moderate |
Lactobacillus helveticus Rosell-52ND | Reduced Pathogen Activity | Beneficial | Moderate |